SciDEX
Main
🏠Dashboard🔬Analyses📈Exchange🏛The Agora🗣Debates🔍Research Gaps⚖Compare
Knowledge
📖Wiki🕸Knowledge Graph🗺Atlas📦Artifacts🧬Protein Designs📄Papers📓Notebooks🔎Search
System
🏛Senate⚔Quests💰Resources🔨Forge📊Experiments🤖Agents🚦Status📑Docs
Info
ℹHow it Works🎨Pitch⭐Showcase📽Demo
📖

RNA Stability and Decay

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-mechanisms-rna-stability
Related Entities
mechanisms-rna-stability
Metadata
slugmechanisms-rna-stability
entity_typemechanism
kg_node_idNone
🌍 Provenance Graph 1 nodes, 0 edges

No provenance edges found

Linked Artifacts (632)
mentions🔬How do dilncRNAs specifically drive molecular crowding and p75%
mentions🔬What determines the specificity of DDR protein recruitment t75%
mentions🔬RNA binding protein dysregulation across ALS FTD AD75%
mentions🔬RNA binding protein dysregulation across ALS FTD and AD75%
mentions🧫Microarray and single-cell RNA analysis of lipid metabolism 70%
mentions🧫dilncRNA-mediated molecular crowding and phase separation70%
mentions🧫Competing endogenous RNA (ceRNA) network construction70%
mentions🧫Factor depletion effects on DDR focus formation in vivo70%
mentions🧫Activity-dependent PGC-1α transcriptional program analysis70%
mentions🧫scRNA-seq analysis of human atherosclerotic plaques70%
mentions🧫Multi-omics analysis of NP137 mechanism in patient biopsies70%
mentions🧫Sevoflurane-induced neurotoxicity (SIN) model in rats70%
mentions🧫PGC-1α expression analysis during PV+ interneuron developmen70%
mentions🧫Multi-omics analysis of myricanol effects on gene expression70%
mentions🧫G3BP1-mediated stress granule assembly via liquid-liquid pha70%
mentions🧫Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m70%
mentions🧫LINC00599-MYH9 liquid-liquid phase separation analysis70%
mentions🧫Single-cell RNA sequencing analysis of human atherosclerotic70%
mentions🧫NPM1 knockout tumor progression study in syngeneic mice70%
mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%
mentions🧫dilncRNA-mediated molecular crowding and phase separation70%
mentions🧫Single-cell RNA-seq analysis of mouse testes with gonadal de70%
mentions🧫Gestational haloperidol exposure effects on hippocampal gene70%
mentions🧫DSB-induced promoter assembly and RNA polymerase II recruitm70%
mentions🧫Machine learning-based identification of C1Q hub genes70%
mentions🧫Single-cell RNA sequencing of microglial states in AD hippoc70%
mentions🧫Single-cell RNA sequencing of EMT states in SCC70%
mentions🧫BDEV injection and recipient microglial transcriptome analys70%
mentions🧫Sevoflurane-induced neurotoxicity (SIN) rat model70%
mentions🧫LC-MS/Western blot analysis of TBK1 in atherosclerotic arter70%
mentions🧫Single-cell RNA sequencing analysis of microglial heterogene70%
mentions🧫Single-nucleus RNA-seq integration analysis70%
mentions🧫Small RNA profiling of neonatal astrocyte EVs and microglia 70%
mentions🧫ZNF263-mediated LINC00599 transcriptional regulation70%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%
mentions🧫s:** - Biochemical binding assays measuring PROTAC selectivi70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
mentions🧫Proposed experiment from debate on Microglia activate astroc70%
mentions🧫s:** - Test whether HCN1 knockout specifically in EC layer I70%
mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam70%
mentions🧫Proposed experiment from debate on Astrocytes adopt A1 (neur70%
mentions🧫Proposed experiment from debate on Epigenetic clocks and bio70%
mentions🧫s:** - Temporal analysis showing mitochondrial defects prece70%
mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%
mentions🧫Proposed experiment from debate on TDP-43 undergoes liquid-l70%
mentions🧫s:** - Compare uptake with/without magnetic particles using 70%
mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%
mentions🧫Proposed experiment from debate on Perivascular spaces and g70%
mentions🧫s:** - Single-cell RNA-seq to measure editing efficiency acr70%
mentions🧫Proposed experiment from debate on Mitochondrial transfer be70%
mentions🧫s:** - Dose-response studies showing therapeutic window with70%
mentions🧫Proposed experiment from debate on Senolytics targeting p16/70%
mentions🧫Proposed experiment from debate on Microglia activate astroc70%
mentions🧫FLS Stimulation and Transcriptomic Analysis70%
mentions🧫Single-cell RNA sequencing of mouse brains70%
mentions🧫Netrin-1 and UNC5B knockdown effects on EMT in vitro70%
mentions🧫LINC00599 role in human PASMC proliferation70%
mentions🧫LINC00599 expression analysis in hypoxic PH models70%
mentions🧫DDR factor depletion and focus formation analysis70%
mentions🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera70%
mentions🧫AAV-LRRK2 IND-Enabling Study Design70%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi70%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau70%
mentions🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio70%
mentions🧫ALS Progression Rate Heterogeneity — mechanism and biomarker70%
mentions🧫ALS Regional Onset and Spread: Network-Level Staging Model70%
mentions🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk70%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%
mentions🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?70%
mentions🧫Animal Model Comparison for Neurodegenerative Disease Therap70%
mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
mentions🧫ApoE4 Function in Alzheimer's Disease70%
mentions🧫Autophagy Enhancement Drug Screening for Neurodegeneration70%
mentions🧫Axonal Transport Dysfunction Validation in Parkinson's 70%
mentions🧫Blood-Based Biomarker Panel for Early AD Detection70%
mentions🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka70%
mentions🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT70%
mentions🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study70%
mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
mentions🧫cGAS-STING Pathway Validation Study in Parkinson's Dise70%
mentions🧫CRISPR Gene Correction Approaches for CBS/PSP70%
mentions🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa70%
mentions🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i70%
mentions🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 70%
mentions🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera70%
mentions🧫Environmental Exposure Causal Attribution in ALS — Experimen70%
mentions🧫Epigenetic Dysregulation in Huntington's Disease — Ther70%
mentions🧫Epigenetic Dysregulation Validation in Parkinson's Dise70%
mentions🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa70%
mentions🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
mentions🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M70%
mentions🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
mentions🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio70%
mentions🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas70%
mentions🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P70%
mentions🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 70%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
mentions🧫Microglial Contributions to Huntington's Disease Pathog70%
mentions🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise70%
mentions🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#70%
mentions🧫Parkinson's Disease Subtype Classification — Precision 70%
mentions🧫Pre-Symptomatic Detection and Intervention Timing in Genetic70%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%
mentions🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD70%
mentions🧫Regulated Necrosis Validation Study in Parkinson's Dise70%
mentions🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel70%
mentions🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec70%
mentions🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D70%
mentions🧫Stress Granule Dysfunction Validation in Parkinson's Di70%
mentions🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki70%
mentions🧫TDP-43 PET Ligand Development for FTD and ALS70%
mentions🧫Experiment Validation: In vitro ThT Assay70%
mentions🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an70%
mentions🧫Tau ASO Therapy70%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy70%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%
mentions🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 70%
mentions🧪Purinergic Signaling Polarization Control70%
mentions🧪Lipid Droplet Dynamics as Phenotype Switches70%
mentions🧪Mechanosensitive Ion Channel Reprogramming70%
mentions🧪Phase-Separated Organelle Targeting69%
mentions🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna69%
mentions🧪Stress Granule Phase Separation Modulators69%
mentions🧪Vagal Afferent Microbial Signal Modulation68%
mentions🧪Cryptic Exon Silencing Restoration67%
related🔬How do dilncRNAs specifically drive molecular crowding and p67%
related🔬What determines the specificity of DDR protein recruitment t67%
related🔬RNA binding protein dysregulation across ALS FTD AD67%
related🔬RNA binding protein dysregulation across ALS FTD and AD67%
mentions🧪RNA Granule Nucleation Site Modulation67%
mentions🧪Cross-Seeding Prevention Strategy66%
mentions🧪Glycine-Rich Domain Competitive Inhibition65%
mentions🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors64%
mentions🧪Vocal Cord Neuroplasticity Stimulation63%
related🧫Microarray and single-cell RNA analysis of lipid metabolism 63%
related🧫dilncRNA-mediated molecular crowding and phase separation63%
related🧫Competing endogenous RNA (ceRNA) network construction63%
related🧫Factor depletion effects on DDR focus formation in vivo63%
related🧫Activity-dependent PGC-1α transcriptional program analysis63%
related🧫scRNA-seq analysis of human atherosclerotic plaques63%
related🧫Multi-omics analysis of NP137 mechanism in patient biopsies63%
related🧫Sevoflurane-induced neurotoxicity (SIN) model in rats63%
related🧫PGC-1α expression analysis during PV+ interneuron developmen63%
related🧫Multi-omics analysis of myricanol effects on gene expression63%
related🧫G3BP1-mediated stress granule assembly via liquid-liquid pha63%
related🧫Myricanol treatment in HFD-induced hyperlipidemic C57BL/6J m63%
related🧫LINC00599-MYH9 liquid-liquid phase separation analysis63%
related🧫Single-cell RNA sequencing analysis of human atherosclerotic63%
related🧫NPM1 knockout tumor progression study in syngeneic mice63%
related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%
related🧫dilncRNA-mediated molecular crowding and phase separation63%
related🧫Single-cell RNA-seq analysis of mouse testes with gonadal de63%
related🧫Gestational haloperidol exposure effects on hippocampal gene63%
related🧫DSB-induced promoter assembly and RNA polymerase II recruitm63%
related🧫Machine learning-based identification of C1Q hub genes63%
related🧫Single-cell RNA sequencing of microglial states in AD hippoc63%
related🧫Single-cell RNA sequencing of EMT states in SCC63%
related🧫BDEV injection and recipient microglial transcriptome analys63%
related🧫Sevoflurane-induced neurotoxicity (SIN) rat model63%
related🧫LC-MS/Western blot analysis of TBK1 in atherosclerotic arter63%
related🧫Single-cell RNA sequencing analysis of microglial heterogene63%
related🧫Single-nucleus RNA-seq integration analysis63%
related🧫Small RNA profiling of neonatal astrocyte EVs and microglia 63%
related🧫ZNF263-mediated LINC00599 transcriptional regulation63%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%
related🧫s:** - Biochemical binding assays measuring PROTAC selectivi63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫Proposed experiment from debate on Microglia activate astroc63%
related🧫s:** - Test whether HCN1 knockout specifically in EC layer I63%
related🧫s:** - GPR32 knockout in microglia should worsen neuroinflam63%
related🧫Proposed experiment from debate on Astrocytes adopt A1 (neur63%
related🧫Proposed experiment from debate on Epigenetic clocks and bio63%
related🧫s:** - Temporal analysis showing mitochondrial defects prece63%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%
related🧫Proposed experiment from debate on TDP-43 undergoes liquid-l63%
related🧫s:** - Compare uptake with/without magnetic particles using 63%
related🧫Proposed experiment from debate on Mitochondrial transfer be63%
related🧫Proposed experiment from debate on Perivascular spaces and g63%
related🧫s:** - Single-cell RNA-seq to measure editing efficiency acr63%
related🧫Proposed experiment from debate on Mitochondrial transfer be63%
related🧫s:** - Dose-response studies showing therapeutic window with63%
related🧫Proposed experiment from debate on Senolytics targeting p16/63%
related🧫Proposed experiment from debate on Microglia activate astroc63%
related🧫FLS Stimulation and Transcriptomic Analysis63%
related🧫Single-cell RNA sequencing of mouse brains63%
related🧫Netrin-1 and UNC5B knockdown effects on EMT in vitro63%
related🧫LINC00599 role in human PASMC proliferation63%
related🧫LINC00599 expression analysis in hypoxic PH models63%
related🧫DDR factor depletion and focus formation analysis63%
related🧫AAV Serotype Comparison for LRRK2 Knockdown in PD Gene Thera63%
related🧫AAV-LRRK2 IND-Enabling Study Design63%
related🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi63%
related🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau63%
related🧫Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio63%
related🧫ALS Progression Rate Heterogeneity — mechanism and biomarker63%
related🧫ALS Regional Onset and Spread: Network-Level Staging Model63%
related🧫Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk63%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%
related🧫Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?63%
related🧫Animal Model Comparison for Neurodegenerative Disease Therap63%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%
related🧫ApoE4 Function in Alzheimer's Disease63%
related🧫Autophagy Enhancement Drug Screening for Neurodegeneration63%
related🧫Axonal Transport Dysfunction Validation in Parkinson's 63%
related🧫Blood-Based Biomarker Panel for Early AD Detection63%
related🧫Blood-Brain Barrier Aging and Neurodegeneration — From Leaka63%
related🧫Mechanism: C9orf72 Hexanucleotide Repeat Expansion in ALS/FT63%
related🧫C9orf72 Phenotype Divergence: ALS vs FTD Mechanism Study63%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%
related🧫cGAS-STING Pathway Validation Study in Parkinson's Dise63%
related🧫CRISPR Gene Correction Approaches for CBS/PSP63%
related🧫Alpha-Synuclein Staging and Spreading in DLB — Spatial Propa63%
related🧫Mechanism: Selective Vulnerability of Dopaminergic Neurons i63%
related🧫Selective Vulnerability of Dopaminergic Neurons — Mechanism 63%
related🧫Down Syndrome Alzheimer's Disease: Mechanisms and Thera63%
related🧫Environmental Exposure Causal Attribution in ALS — Experimen63%
related🧫Epigenetic Dysregulation in Huntington's Disease — Ther63%
related🧫Epigenetic Dysregulation Validation in Parkinson's Dise63%
related🧫Epigenetic Regulation Dysfunction in Alzheimer's and Pa63%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De63%
related🧫Frontal and Temporal Lobe Selective Vulnerability in FTD — M63%
related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud63%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%
related🧫FXTAS Phenotypic Penetrance: Why Only 40% of FMR1 Premutatio63%
related🧫Lifestyle Intervention Mechanisms in Alzheimer's Diseas63%
related🧫Validate Mitochondria-Lysosome Contact Site Dysfunction in P63%
related🧫Mutant Huntingtin (mHTT) Clearance Mechanisms — Therapeutic 63%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%
related🧫Microglial Contributions to Huntington's Disease Pathog63%
related🧫NLRP3 Inflammasome Validation Study in Parkinson's Dise63%
related🧫Oligodendrocyte-Myelin Dysfunction Validation in Parkinson&#63%
related🧫Parkinson's Disease Subtype Classification — Precision 63%
related🧫Pre-Symptomatic Detection and Intervention Timing in Genetic63%
related🧫Progranulin Replacement Therapy for FTD — Vector Development63%
related🧫Mechanism: Progranulin Loss and TDP-43 Pathology in FTD63%
related🧫Regulated Necrosis Validation Study in Parkinson's Dise63%
related🧫Spinocerebellar Ataxia (SCA) Disease-Modifying Therapy Devel63%
related🧫Selective Neuronal Vulnerability to Aging — Mapping Why Spec63%
related🧫Sirtuin Pathway Dysfunction Validation in Parkinson's D63%
related🧫Stress Granule Dysfunction Validation in Parkinson's Di63%
related🧫Synaptic Vesicle Trafficking Dysfunction Validation in Parki63%
related🧫TDP-43 PET Ligand Development for FTD and ALS63%
related🧫Experiment Validation: In vitro ThT Assay63%
related🧫TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an63%
related🧫Tau ASO Therapy63%
related🧫Microglial TREM2 Agonist In Vivo Efficacy63%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia63%
related🧫Wilson Disease Neurodegeneration: Mechanism and Therapeutic 63%
related🧪Purinergic Signaling Polarization Control63%
related🧪Lipid Droplet Dynamics as Phenotype Switches63%
related🧪Mechanosensitive Ion Channel Reprogramming63%
related🧪Phase-Separated Organelle Targeting62%
related🧪Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna62%
related🧪Stress Granule Phase Separation Modulators62%
related🧪Vagal Afferent Microbial Signal Modulation61%
related🧪Cryptic Exon Silencing Restoration60%
related🧪RNA Granule Nucleation Site Modulation60%
related🧪Cross-Seeding Prevention Strategy60%
mentions🔬What are the mechanisms underlying rna binding protein dysre60%
related🧪Glycine-Rich Domain Competitive Inhibition59%
related🧪Palmitoylation-Targeted BACE1 Trafficking Disruptors57%
related🧪Vocal Cord Neuroplasticity Stimulation56%
related🔬What are the mechanisms underlying rna binding protein dysre54%
mentions🧪Liquid-Liquid Phase Separation Modifier Therapy50%
mentions🧪APOE-Dependent Autophagy Restoration50%
mentions🧪RNA-Binding Competition Therapy for TDP-43 Cross-Seeding50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying rna binding protein dysre50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What are the mechanisms underlying selective vulnerability o50%
related🔬What are the mechanisms underlying 4r-tau strain-specific sp50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying autophagy-lysosome pathwa50%
related🔬What are the mechanisms underlying digital biomarkers and ai50%
related🔬What are the mechanisms underlying senolytic therapy for age50%
related🔬What are the mechanisms underlying neuroinflammation resolut50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
related🔬Investigate how lipid raft composition (cholesterol metaboli50%
related🔬What are the mechanisms underlying sleep disruption as cause50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying mitochondrial transfer be50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the mechanisms underlying perivascular spaces and g50%
related🔬Analyze circuit-level changes in neurodegeneration using All50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬What gene expression changes in the aging mouse brain predic50%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen50%
related🔬What cell types are most vulnerable in Alzheimers Disease ba50%
related🔬What cell types are most vulnerable in Alzheimer's Dise50%
related🔬What are the mechanisms by which tau pathology spreads throu50%
see_also📖AAIC 2026: Tau-PET Imaging and Fluid Biomarker Integration45%
see_also📖Alpha-Synuclein PET Imaging and Biomarker Advances45%
see_also📖Alpha-Synuclein Seeding Assays (RT-QuIC and PMCA)45%
see_also📖Imaging Biomarkers for Corticobasal Syndrome and Progressive45%
see_also📖Cell-Free DNA Biomarkers in Neurodegeneration45%
see_also📖Exosomal Biomarkers in Neurodegeneration45%
see_also📖Exosomal miR-155 in Neurodegeneration45%
see_also📖IL-6 (Interleukin-6) in Neurodegeneration45%
see_also📖Liquid Biopsy in Neurodegeneration45%
see_also📖Metabolomic Biomarkers in Neurodegeneration45%
see_also📖Multi-Analyte Biomarker Panel for Parkinson's Disease D45%
see_also📖Neuroimaging Biomarkers for Neurodegeneration45%
see_also📖NPTX1 and NPTXR CSF Markers Predict Alzheimer's Disease45%
see_also📖Polygenic Risk Score Integration Panel for Alzheimer's 45%
see_also📖CSF and Blood Biomarkers in Progressive Supranuclear Palsy45%
see_also📖p-Tau Biomarker in Immunoglobulin Light Chain and Transthyre45%
see_also📖Speech and Cognitive Biomarkers for Alzheimer's Disease45%
see_also📖Synaptic Biomarkers in Neurodegeneration45%
see_also📖VILIP-1 and YKL-40 - Alzheimer's Disease Biomarkers45%
see_also📖BEACoN Study - Biomarker Exploration in Aging, Cognition and45%
see_also📖BLAAC PD - Black and African Americans Connections to PD (NC45%
see_also📖Clostridium Butyricum for Motor and Non-motor Symptoms in Pa45%
see_also📖CNversyt and Megan Rodden ALS Trials45%
see_also📖Cognitive and Speech Rehabilitation in CBS (NCT05823421)45%
see_also📖Digital Therapeutic Platform for Swallowing and Drooling Pro45%
see_also📖First-in-Human 4R Tau Ligand Study in PSP (NCT07348276)45%
see_also📖Gait Analysis Parameter and Upper Limb Evaluation in Neurolo45%
see_also📖Gait and Upper Limb Evaluation in PSP (NCT07136844)45%
see_also📖GBA Brain Molecular Imaging and Blood Biomarkers for Precisi45%
see_also📖Utilisation of Health Services and Quality of Life in Atypic45%
see_also📖Phase 3 Study to Compare the Efficacy and Safety of Masitini45%
see_also📖Safety and Clinical Outcomes Study: Amniotic and Umbilical C45%
see_also📖A Phase IIB, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖A Phase III, Randomized, Double-Blind, Placebo-Controlled, M45%
see_also📖A Multicenter, Phase III, Randomized, Double Blind, Placebo-45%
see_also📖A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-C45%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 45%
see_also📖Long-term Effects of Hearing Intervention on Brain Health in45%
see_also📖A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial45%
see_also📖A 6-month & 18-month Prospective, Randomized, Placebo-co45%
see_also📖A Phase 3, Randomized, Double-blind, Placebo-controlled, Par45%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St45%
see_also📖Olfactory Mucosa, Blood and Urine for Identification of Earl45%
see_also📖PCDH19-Related Epilepsy (EFMR) — Preclinical Gene Therapy Pr45%
see_also📖Whole-Body Photobiomodulation for Motor and Cognitive Change45%
see_also📖PI-2620 Tau PET Phase 3 (NCT05456503) - FTLD and Atypical AD45%
see_also📖Quality of Life and Caregiver Burden in PSP (NCT03638505)45%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime45%
see_also📖Silymarin for Neuroprotection and Symptom Management in Park45%
see_also📖Social Behaviors and Quality of Life in Parkinson's Dis45%
see_also📖Swedish BioFINDER 2 Study: Biomarkers and Neurodegeneration 45%
see_also📖Clinical Efficacy and Mechanism of tDCS for Dysphagia in Par45%
see_also📖alexander-disease45%
see_also📖Alexander Disease Genetic Variants45%
see_also📖Adult-Onset Leukoencephalopathy with Axonal Spheroids and Pi45%
see_also📖ATP13A9 and Parkinson's Disease45%
see_also📖Beta-Propeller Protein-Associated Neurodegeneration (BPAN)45%
see_also📖Callosal Disconnection and Interhemispheric Dysfunction in C45%
see_also📖Cross-National Cancer-Dementia Correlation and Shared Diseas45%
see_also📖Cancer-Dementia Inverse Correlation: Epidemiological Evidenc45%
see_also📖CARASIL (Cerebral Autosomal Recessive Arteriopathy with Subc45%
see_also📖Caregiver Burden and Support in Corticobasal Syndrome45%
see_also📖Caregiver Support and Palliative Care in Atypical [Parkinson45%
see_also📖Clinical Phenotypes and Subtypes of Corticobasal Syndrome45%
see_also📖Natural History and Prognosis of Corticobasal Syndrome45%
see_also📖China Neurodegeneration Epidemiology45%
see_also📖DALY Methodology — Neurodegeneration45%
see_also📖Disease Progression & Staging in Neurodegeneration45%
see_also📖Dysphagia and Nutritional Management in Corticobasal Syndrom45%
see_also📖Economic Burden — Neurodegeneration45%
see_also📖Environmental Toxins and Parkinson's Risk45%
see_also📖European Neurodegeneration Epidemiology45%
see_also📖Familial vs Sporadic Neurodegeneration Comparison45%
see_also📖Global Neurodegeneration Epidemiology45%
see_also📖HIV-Associated Neurocognitive Disorders (HAND)45%
see_also📖Hemiballismus and Hemichorea in Corticobasal Syndrome45%
see_also📖Hereditary Sensory and Autonomic Neuropathy (HSAN)45%
see_also📖India Neurodegeneration Epidemiology45%
see_also📖Investment Landscape: ALS45%
see_also📖Investment Landscape: Frontotemporal Dementia45%
see_also📖Investment Landscape: Huntington's Disease45%
see_also📖Investment Landscape: Parkinson's Disease45%
see_also📖Japan Neurodegeneration Epidemiology45%
see_also📖Japanese and German Case Series in Corticobasal Degeneration45%
see_also📖Jervell and Lange-Nielsen Syndrome45%
see_also📖LRRK2 Gene Variants and Mutations45%
see_also📖Manganese-Related Neurodegeneration (Manganism)45%
see_also📖MELAS Syndrome (Mitochondrial Encephalomyopathy, Lactic Acid45%
see_also📖Mirror Therapy and Sensory Re-education in Corticobasal Synd45%
see_also📖mitochondrial-dysfunction-neurodegeneration-comparison45%
see_also📖Mitochondrial Diseases and Neurodegeneration Comparison Matr45%
see_also📖Mitochondrial Membrane Protein-Associated Neurodegeneration 45%
see_also📖Neurodegeneration with Brain Iron Accumulation (NBIA)45%
see_also📖Potential Impact Measures — Neurodegeneration45%
see_also📖Nutritional Support and Dietary Interventions in Corticobasa45%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%
see_also📖Physical and Occupational Therapy in Corticobasal Syndrome45%
see_also📖Pantothenate Kinase-Associated Neurodegeneration (PKAN)45%
see_also📖PLA2G6-Associated Neurodegeneration (PLAN)45%
see_also📖Postural Dysfunction and Abnormalities in Corticobasal Syndr45%
see_also📖Pseudobulbar Affect and Emotional Lability in Corticobasal S45%
see_also📖Healthcare Economics and Cost of Illness in Progressive Supr45%
see_also📖PSP and Idiopathic Normal Pressure Hydrocephalus: Clinical O45%
see_also📖Quality of Life and Caregiver Burden in Progressive Supranuc45%
see_also📖Speech and Voice Disorders in PSP45%
see_also📖Sandhoff Disease45%
see_also📖Sialorrhea and Drooling in Corticobasal Syndrome45%
see_also📖Simultanagnosia and Balint's Syndrome in Corticobasal S45%
see_also📖Sleep Disorders in Neurodegeneration45%
see_also📖SNCA Gene Variants and Mutations45%
see_also📖Speech Therapy and Communication Aids in Corticobasal Syndro45%
see_also📖US Neurodegeneration Epidemiology45%
see_also📖Vocational Rehabilitation and Driving in Corticobasal Syndro45%
see_also📖Voice and Speech in Corticobasal Syndrome45%
see_also📖Extracellular Vesicle and Tunneling Nanotube-Mediated Spread45%
see_also📖ABCA7 Lipid Transport and Microglial Phagocytosis AD Causal 45%
see_also📖acetylcholine-signaling-neurodegeneration45%
see_also📖Shared Mechanisms Between Alzheimer and Parkinson Disease45%
see_also📖Advanced Glycation End Products in Neurodegeneration45%
see_also📖Advanced In Vitro Models for Neurodegeneration — Organoids, 45%
see_also📖ALS Biomarkers and Disease Monitoring45%
see_also📖Amylin Signaling in Neurodegeneration45%
see_also📖Antibody Therapy in Neurodegeneration45%
see_also📖Antisense Oligonucleotide (ASO) Therapy in Neurodegeneration45%
see_also📖APOE4 and Alzheimer's Disease Risk45%
see_also📖Autosis Pathway in Neurodegeneration45%
see_also📖Axon Guidance Pathways in Neurodegeneration45%
see_also📖Basal Ganglia Circuit Dysfunction in Neurodegeneration45%
see_also📖Blood-Brain Barrier and Neuroimmune Interface in CBS/PSP45%
see_also📖Blood-Brain Barrier Dysfunction and Therapeutic Delivery for45%
see_also📖becn1-autophagy-initiation-neurodegeneration-causal-chain45%
see_also📖Braak Staging and Tau Propagation Pathway45%
see_also📖C9orf72 Repeat Expansions in CBS and PSP45%
see_also📖CaMKII Signaling Pathway in Neurodegeneration45%
see_also📖Carbonic Anhydrase Modulator Therapy in Neurodegeneration45%
see_also📖Myoclonus and Cortical Hyperexcitability in Corticobasal Syn45%
see_also📖Multimodal Diagnostic Algorithm for CBS and PSP45%
see_also📖CBS/PSP Panxoneopathy and Membrane Biology45%
see_also📖VEGF and Angiogenesis Dysregulation in CBS/PSP45%
see_also📖Pupillometry and Chromatic Pupillometry in Corticobasal Synd45%
see_also📖Cerebral Amyloid Angiopathy in Neurodegeneration45%
see_also📖Cerebral Amyloid Angiopathy Pathway in Neurodegeneration45%
see_also📖Cholinergic System Dysfunction in Neurodegeneration45%
see_also📖Chrononutrition and Time-Restricted Eating in Neurodegenerat45%
see_also📖Neural Circuits in Neurodegeneration45%
see_also📖Cognitive Reserve and Resilience in Neurodegeneration45%
see_also📖Computational Disease Models for Neurodegeneration45%
see_also📖Convergent Pathways in Neurodegeneration45%
see_also📖Copper Homeostasis in Neurodegeneration45%
see_also📖COVID-19 Neurodegeneration Mechanism45%
see_also📖Diffusion MRI (DTI) in Neurodegeneration45%
see_also📖Digital Phenotyping in Neurodegeneration45%
see_also📖Down Syndrome Neurodegeneration Pathway45%
see_also📖Dystrophic Neurites in Neurodegeneration45%
see_also📖Endocannabinoid System in Neurodegeneration45%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%
see_also📖Endosomal Sorting Defects in Neurodegeneration45%
see_also📖Endothelin Signaling Pathway in Neurodegeneration45%
see_also📖epigenetics-neurodegeneration45%
see_also📖ESCRT-III Inhibition by Alpha-Synuclein in Neurodegeneration45%
see_also📖FA2H-Associated Neurodegeneration Pathway45%
see_also📖FTDP-17 Clinical Phenotypes and Disease Progression45%
see_also📖FTLD-TDP Subtypes and Mechanisms45%
see_also📖Farnesoid X Receptor (FXR) Signaling in Neurodegeneration45%
see_also📖Galectin-3 Mechanism in Neurodegeneration45%
see_also📖Gangliosides in Neurodegeneration45%
see_also📖GBA Glucocerebrosidase Dysfunction and Parkinson's Dise45%
see_also📖GDF15/GDF11 Signaling in Neurodegeneration45%
see_also📖GDNF Signaling Pathway in Neurodegeneration45%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t45%
see_also📖Ghrelin Signaling Pathway in Neurodegeneration45%
see_also📖Glial Tau Pathology in PSP and CBD45%
see_also📖Glucocorticoid Signaling Pathway in Neurodegeneration45%
see_also📖Glycosylation in Neurodegeneration45%
see_also📖Glymphatic Clearance Hypothesis — Impaired Aβ and Tau Remova45%
see_also📖Glymphatic and Vascular Clearance Dysfunction in 4R-Tauopath45%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration45%
see_also📖Hippocampal Neurogenesis in Neurodegeneration45%
see_also📖Histone Modification Pathways in Neurodegeneration45%
see_also📖HMGB1 Signaling in Neurodegeneration45%
see_also📖Homocysteine Neurotoxicity and Neurodegeneration45%
see_also📖IGF-1 Signaling Pathway in Neurodegeneration45%
see_also📖IL-1 Signaling Pathway in Neurodegeneration45%
see_also📖Integrated Stress Response in Neurodegeneration45%
see_also📖interleukin-6-signaling-neurodegeneration45%
see_also📖Intrinsic Apoptosis Pathway in Neurodegeneration45%
see_also📖Ion Channel Dysfunction in Neurodegeneration: Cross-Disease 45%
see_also📖Iron and Neuromelanin Accumulation in PSP45%
see_also📖Kidney-Brain Neurodegeneration Axis45%
see_also📖Lipid Dysregulation in Neurodegeneration45%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration45%
see_also📖LRRK2 Kinase Activation and Endolysosomal Dysfunction in Par45%
see_also📖Lysosomal Calcium Dysregulation in Neurodegeneration45%
see_also📖Magnetic Resonance Spectroscopy in Neurodegeneration45%
see_also📖Metal Homeostasis Dysregulation in Neurodegeneration45%
see_also📖Metal Homeostasis in Neurodegeneration45%
see_also📖Microglial Priming Pathway in Neurodegeneration45%
see_also📖MicroRNA Dysfunction in Neurodegeneration45%
see_also📖Mineralocorticoid Receptor Signaling in Neurodegeneration45%
see_also📖Mitochondrial Dynamics Pathway in Neurodegeneration45%
see_also📖Mitochondrial Fusion in Neurodegeneration45%
see_also📖Molecular Chaperones in Neurodegeneration45%
see_also📖MSA Clinical Features and Diagnosis45%
see_also📖mTOR Signaling in Autophagy and Lysosomal Function45%
see_also📖mTOR Signaling in Neurodegeneration45%
see_also📖mTOR Signaling Pathway in Neurodegeneration45%
see_also📖Neural Circuit Disruption in Neurodegeneration45%
see_also📖Neurexin/Neuroligin Synaptic Adhesion Modulator Therapy in N45%
see_also📖Neurofilament Light Chain (NfL) Mechanism in Neurodegenerati45%
see_also📖Neuroinflammation in Parkinson's Disease Dementia and D45%
see_also📖Neuronal Hyperexcitability in Neurodegeneration45%
see_also📖Neuropil Threads in Neurodegeneration45%
see_also📖Neuroresilience Mechanisms and Evidence45%
see_also📖Neurotensin Signaling in Neurodegeneration45%
see_also📖Neurovascular Unit Dysfunction in Neurodegeneration45%
see_also📖NF-kB Signaling Pathway in Neurodegeneration45%
see_also📖Nitric Oxide Signaling in Neurodegeneration45%
see_also📖NLRP3 Inhibitors in Parkinson's Disease: Research and C45%
see_also📖Noradrenergic Signaling Pathway in Neurodegeneration45%
see_also📖Neuropeptide Y Signaling in Neurodegeneration45%
see_also📖NRF2 Signaling Pathway in Neurodegeneration45%
see_also📖Nuclear Pore Complex Dysfunction in Neurodegeneration45%
see_also📖Orexin Signaling in Neurodegeneration45%
see_also📖OSK Reprogramming and Yamanaka Factors in Neurodegeneration45%
see_also📖P-Body (Processing Body) Pathway in Neurodegeneration45%
see_also📖Paranodal Dysfunction in Neurodegeneration45%
see_also📖Paraptosis in Neurodegeneration45%
see_also📖Parthanatos in Neurodegeneration45%
see_also📖Pericyte Loss in Neurodegeneration45%
see_also📖Peripheral Immune-Brain Crosstalk in Neurodegeneration45%
see_also📖Pesticides and Parkinson Disease (Pest-PD) — NCT0642031045%
see_also📖PKR Pathway in Neurodegeneration45%
see_also📖PPAR Signaling Pathway in Neurodegeneration45%
see_also📖Prion Diseases in Neurodegeneration45%
see_also📖Prion-Like Spread in Neurodegeneration45%
see_also📖Prion Protein Metabolism in Neurodegeneration45%
see_also📖Progesterone Signaling Pathway in Neurodegeneration45%
see_also📖Prognostic Biomarkers in Neurodegeneration45%
see_also📖Protein Aggregation Comparison in Neurodegeneration45%
see_also📖Protein Aggregation Seeds in Neurodegeneration45%
see_also📖Protein O-GlcNAcylation Pathway in Neurodegeneration45%
see_also📖Advanced Proteolysis and Ubiquitin System Targeting in CBS/P45%
see_also📖Cortical Involvement and Neurodegeneration in Progressive Su45%
see_also📖Gait and Balance Disorders in Progressive Supranuclear Palsy45%
see_also📖HLA Haplotypes and Neuroinflammatory Profiles in PSP45%
see_also📖PSP Liquid-Liquid Phase Separation and Biomolecular Condensa45%
see_also📖PSP Lysosomal Dysfunction and Autophagy Impairment45%
see_also📖Metabolic Dysfunction and Insulin Resistance in Progressive 45%
see_also📖Pupillary and Visual Dysfunction in Progressive Supranuclear45%
see_also📖PSP Tau Propagation and Spreading Mechanisms45%
see_also📖PSP Weight Loss and Cachexia45%
see_also📖Purinergic Signaling in Neurodegeneration45%
see_also📖Quantum Biology and Coherent Energy Transfer in Neurodegener45%
see_also📖R-Loop Stress in Neurodegeneration45%
see_also📖RAN Translation in Neurodegeneration45%
see_also📖Retinal Degeneration Pathway in Neurodegeneration45%
see_also📖Ribosome Dysfunction in Neurodegeneration45%
see_also📖RNA Splicing in Neurodegeneration45%
see_also📖RNA-Targeted Therapies in Neurodegeneration45%
see_also📖Ribonuclease κ and Circular RNAs: A New Mechanism of Aging a45%
see_also📖S100 Protein Signaling Pathway in Neurodegeneration45%
see_also📖Senescent Cell Clearance in Neurodegeneration45%
see_also📖Serotonergic Dysfunction in Neurodegeneration45%
see_also📖Sex Differences in Neurodegeneration45%
see_also📖Short Chain Fatty Acids in Neurodegeneration45%
see_also📖Sigma-1 Receptor Signaling in Neurodegeneration45%
see_also📖Sirtuin-Mitochondrial Biogenesis Axis in Neurodegeneration45%
see_also📖Sleep Architecture Changes in CBS and PSP45%
see_also📖Sleep and Circadian Dysfunction in Alzheimer's Disease45%
see_also📖Sleep Dysfunction in Neurodegeneration45%
see_also📖Somatic Mutations and Brain Mosaicism45%
see_also📖Speech and Language Deficits in Corticobasal Syndrome45%
see_also📖SUMOylation in Neurodegeneration45%
see_also📖Synaptic Loss and Dysfunction Pathway45%
see_also📖synaptic-vesicle-cycling-neurodegeneration45%
see_also📖Synthetic Lethality and PARP Inhibition in Neurodegeneration45%
see_also📖Systemic Infection and Tau Pathology Acceleration45%
see_also📖T-Cell Dysfunction in Neurodegeneration45%
see_also📖Tau Seeding and Propagation Pathway45%
see_also📖TBK1 Autophagy and Neuroinflammation ALS/FTD Causal Chain45%
see_also📖Tertiary Lymphoid Organs in Neurodegeneration45%
see_also📖Therapeutic Targets in Neurodegeneration45%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%
see_also📖ubiquitin-proteasome-dysfunction-neurodegeneration45%
see_also📖Ubiquitin-Proteasome System Dysfunction in Neurodegeneration45%
see_also📖Vagus Nerve Pathway in Neurodegeneration45%
see_also📖VEGF Signaling and Cerebral Angiogenesis in Neurodegeneratio45%
see_also📖vip-vasoactive-intestinal-peptide-signaling-neurodegeneratio45%
see_also📖WNK1-Bilirubin Signaling in Neuroinflammation and Neurodegen45%
see_also📖Wnt/β-Catenin Signaling Pathway in Neurodegeneration45%
see_also📖ALS Therapeutic Landscape — Programs by Phase and Modality45%
mentions🧫LRRK2/GBA Mutation Carrier Resilience — Why Some Carriers Ne44%
mentions🔬What are the mechanisms underlying selective vulnerability o40%
mentions🔬What are the mechanisms underlying 4r-tau strain-specific sp40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying astrocyte reactivity subt40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
mentions🔬What are the mechanisms underlying microglia-astrocyte cross40%
mentions🔬What are the mechanisms underlying apoe4 structural biology 40%
mentions🔬What are the mechanisms underlying autophagy-lysosome pathwa40%
mentions🔬What are the mechanisms underlying digital biomarkers and ai40%
mentions🔬What are the mechanisms underlying senolytic therapy for age40%
mentions🔬What are the mechanisms underlying neuroinflammation resolut40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying what are the mechanisms b40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬What are the mechanisms underlying protein aggregation cross40%
mentions🔬What are the mechanisms underlying mechanistic role of apoe 40%
mentions🔬What are the mechanisms underlying sleep disruption as cause40%
mentions🔬What are the mechanisms underlying synaptic pruning by micro40%
mentions🔬What are the mechanisms underlying mitochondrial transfer be40%
mentions🔬What are the mechanisms underlying epigenetic clocks and bio40%
mentions🔬What are the mechanisms underlying perivascular spaces and g40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬What gene expression changes in the aging mouse brain predic40%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen40%
mentions🔬What cell types are most vulnerable in Alzheimers Disease ba40%
mentions🔬What cell types are most vulnerable in Alzheimer's Dise40%
mentions🔬What are the mechanisms by which tau pathology spreads throu40%
SciDEX — scidex.ai — Dashboard | Mission Control | Status | How it Works | GitHub